- NRXP Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
-
Institutional
- Shorts
NRx Pharmaceuticals (NRXP) Institutional ownership
Company Profile
Type | Filer | #Shares | Filed | For date | #Previous | %Chg | Prev. Date |
---|---|---|---|---|---|---|---|
13F-HR
|
AdvisorShares Investments | 310.31 k | 14 Feb 25 | 31 Dec 24 | 130.09 k | +139% | 30 Sep 24 |
13F-HR
|
Morgan Stanley | 4.40 k | 14 Feb 25 | 31 Dec 24 | 4.40 k | 0% | 30 Sep 24 |
13F-HR
|
Millennium Management | 27.62 k | 14 Feb 25 | 31 Dec 24 | 0.00 | +∞% | 30 Sep 24 |
13F-HR
|
Citadel Advisors | 19.60 k | 14 Feb 25 | 31 Dec 24 | 35.30 k | -44% | 30 Sep 24 |
13F-HR/A
|
Morgan Stanley | 4.40 k | 14 Feb 25 | 30 Sep 24 | 43.95 k | -90% | 31 Mar 24 |
13F-HR
|
Bank of America | 3.30 k | 14 Feb 25 | 31 Dec 24 | 95.00 | 30 Sep 24 | |
13F-HR
|
Sassicaia Capital Advisers | 15.00 k | 14 Feb 25 | 31 Dec 24 | 0.00 | +∞% | 30 Sep 24 |
13F-HR
|
Squarepoint Ops | 25.30 k | 14 Feb 25 | 31 Dec 24 | 0.00 | +∞% | 30 Sep 24 |
13F-HR
|
UBS | 3.91 k | 14 Feb 25 | 31 Dec 24 | 15.25 k | -74% | 30 Sep 24 |
13F-HR
|
State Street | 16.72 k | 14 Feb 25 | 31 Dec 24 | 16.72 k | 0% | 30 Sep 24 |
This data is updated daily from 13F, 13D and 13G SEC filings.
Faded values represent incomplete data for the quarter, where values have been used from the previous quarter for institutions that haven't filed updated data yet.
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.